Sedat Evran - 05 Sep 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Signature
/s/ Sedat Evran
Issuer symbol
BIO
Transactions as of
05 Sep 2025
Net transactions value
-$81,834
Form type
4
Filing time
09 Sep 2025, 16:24:03 UTC
Previous filing
05 Mar 2025
Next filing
21 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
EVRAN SEDAT EVP, Global Supply Chain C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES /s/ Sedat Evran 09 Sep 2025 0001993147

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIO.B Bio-Rad A Common Stock Options Exercise $0 +864 +92% $0.000000 1,801 06 Sep 2025 Direct F1, F2
transaction BIO BIO.B Bio-Rad A Common Stock Tax liability $81,834 -277 -15% $295.43 1,524 06 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIO.B Restricted Stock Units Award $0 +4,110 $0.000000 4,110 05 Sep 2025 Bio-Rad A Common Stock 4,110 $0.000000 Direct F3, F4
transaction BIO BIO.B Restricted Stock Units Options Exercise $0 -864 -25% $0.000000 2,592 06 Sep 2025 Bio-Rad A Common Stock 864 $0.000000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 56.9880 and 26.7190 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2025 and 06/30/2025, respectively.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.